tm logo
WENHAEVA
Live/Registered
REGISTERED

on 10 Dec 2024

Last Applicant/ Owned by

Emil-von-Behring Str. 76

Marburg

DE

D-35041

Serial Number

97777730 filed on 02th Feb 2023

Registration Number

7593324 registered on 10th Dec 2024

in the Principal Register

Correspondent Address

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

SUITE 400

WASHINGTON, DC 20007

United States

Filing Basis

No Filing Basis

Disclaimer

NO DATA

WENHAEVA

Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and b Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97777730

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 034845.368

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
10th Dec 2024REGISTERED-PRINCIPAL REGISTER
10th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Sep 2024PUBLISHED FOR OPPOSITION
21st Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
24th Jul 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
24th Jul 2024TEAS/EMAIL CORRESPONDENCE ENTERED
24th Jul 2024ASSIGNED TO LIE
05th Feb 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED